How to Administer Pantoprazole IV Drip
For upper gastrointestinal bleeding with high-risk stigmata after endoscopic hemostasis, administer pantoprazole as an 80 mg IV bolus followed by 8 mg/hour continuous infusion for exactly 72 hours. 1, 2
Standard Dosing Protocol
Initial Bolus and Continuous Infusion
- Give 80 mg pantoprazole IV bolus over 2-15 minutes, immediately followed by 8 mg/hour continuous IV infusion for 72 hours 1, 2, 3
- Start this regimen as soon as possible, even before endoscopy is performed, though endoscopy should not be delayed 1, 2, 4
- The continuous infusion is critical to maintain gastric pH above 6, which is necessary for platelet aggregation and clot stability 2
Preparation for 15-Minute Infusion (Bolus)
- Reconstitute one 40 mg vial with 10 mL of 0.9% sodium chloride 3
- For 80 mg dose, combine contents of two vials 3
- Further dilute with 80 mL of 5% dextrose, 0.9% sodium chloride, or lactated Ringer's to total volume of 100 mL (final concentration approximately 0.8 mg/mL) 3
- Administer over 15 minutes at approximately 7 mL/minute 3
Preparation for 2-Minute Infusion (Bolus Alternative)
- Reconstitute each 40 mg vial with 10 mL of 0.9% sodium chloride (final concentration 4 mg/mL) 3
- Administer total volume from both vials over at least 2 minutes 3
Continuous Infusion Setup
- After bolus, begin 8 mg/hour continuous infusion for exactly 72 hours 1, 2
- Use dedicated IV line or Y-site administration 3
- Flush line before and after with 5% dextrose, 0.9% sodium chloride, or lactated Ringer's 3
Post-Infusion Management
Transition to Oral Therapy
- After completing 72-hour IV infusion, switch to oral pantoprazole 40 mg twice daily on days 4-14 1, 2
- Then continue oral pantoprazole 40 mg once daily from day 15 onward for total of 6-8 weeks to allow complete mucosal healing 1, 2
Storage and Compatibility
Storage Guidelines
- Reconstituted solution may be stored up to 24 hours at room temperature and does not need light protection 3
- Do not freeze reconstituted or diluted solutions 3
Compatibility Warnings
- Midazolam is incompatible with Y-site administration of pantoprazole 3
- Pantoprazole may not be compatible with products containing zinc 3
- Immediately discontinue infusion if precipitation or discoloration occurs 3
Evidence Supporting This Protocol
Mortality and Rebleeding Benefits
- High-dose continuous infusion reduces mortality (OR 0.56,95% CI 0.34-0.94) compared to no PPI or H2-receptor antagonists 1
- Reduces rebleeding rates (OR 0.43,95% CI 0.29-0.63) in high-risk patients 1
- Decreases need for surgery 1
pH Control
- The 80 mg bolus followed by 8 mg/hour infusion rapidly increases intragastric pH to approximately 6 within 15-30 minutes 5
- Maintains pH ≥6 for 64% of time during first 48 hours, which is optimal for clot stability 5
Critical Caveats
What NOT to Do
- Never use PPI therapy as replacement for urgent endoscopy in active bleeding - PPIs are adjunctive therapy only 1, 2, 4
- Do not use lower doses in high-risk patients - the mortality benefit is seen only with high-dose continuous infusion 1
- Do not discontinue oral PPI therapy before completing 6-8 weeks, as this prevents adequate mucosal healing 1, 4
Patient Selection
- This high-dose regimen is most beneficial for patients with high-risk endoscopic stigmata: active bleeding, visible vessel, or adherent clot 2, 4
- Benefits are less pronounced in low-risk lesions (clean-based ulcers) 6